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Introduction
　Gravesʼ disease is the most common cause of hyperthy-
roidism. In Europe and Japan, there has been a greater phy-
sician preference for antithyroid medication and surgery (1). 
If surgery is chosen as the primary therapy for Gravesʼ dis-
ease, the American Thyroid Association and American As-
sociation of Clinical Endocrinologists recommend either a 
near-total or total thyroidectomy as the procedure of choice 
(1). Temporary symptoms of hypocalcemia, such as par-
esthesia of the distal extremities and circumoral area, the 
Chovostek and Trousseau sign, muscle cramps, laryngos-
pasms, tetany, and seizures, are postoperative complications 
of the surgical treatment of Gravesʼ disease. Hypocalcemic 
symptoms lead to patient distress and prolonged hospital-
ization (2). In addition, patients undergoing thyroidectomy 
for Gravesʼ disease are more likely to have postoperative 
hypocalcemia than patients undergoing total thyroidectomy 
for other indications (3). In this study, we evaluated the fac-
tors associated with postoperative symptomatic hypocalce-
mia by examining the standard clinical parameters mea-
sured for all preoperative patients.
Patients and Methods
　We studied 109 patients with Gravesʼ disease who under-
went near-total, or total thyroidectomy between January 
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2005 and August 2010. Gravesʼ disease was defined by the 
presence of thyrotoxicosis, a diffuse goiter, and serum TSH 
receptor antibody or thyroid stimulating antibody. Forty pa-
tients were operated on due to side effects associated with 
the antithyroid medication. Twenty-four patients were oper-
ated on due to a poor control of the thyroid function. Fifteen 
patients were operated on due to a poor compliance of anti-
thyroid medication. Thirty patients were operated on at the 
patientsʼ requests, due to such factors as early remission, 
cosmetic deformity, and a desire to conceive a child soon 
after treatment
　Potassium iodide (KI) was given for 1 or 2 weeks prior to 
surgery to all patients. Steroid treatment was added for pa-
tients who still exhibited hyperthyroidism on admission, 
despite the administration of KI. 
　Free free thyroxin (T4), free triiodothyronine (T3), thy-
roid stimulating hormone (TSH), alkaline phosphatase 
(ALP), albumin, phosphorus, and total calcium were exam-
ined before the administration of KI. After a week of the 
administration of KI, Free T4, free T3, TSH were examined 
again. ALP and total calcium were examined on the first 
postoperative day. After the patients were discharged, we fol-
lowed hypocalcemia every 3 to 4 months until it improved.
　Postoperative symptomatic hypocalcemia was defined as 
follows. The hypocalcemic symptoms such as a tingling or 
ʻpins and needlesʼ sensation in and around the mouth and 
lips, and in the extremities, muscular cramps, carpopedal 
spasms, and tetany developed during a week after the op-
eration. Moreover, treatment of the hypocalcemia, which 
involved the infusion of calcium gluconate and oral calcium 
and vitamin D administration, improved the symptoms. 
There were no patients with permanent hypoparathyroid-
ism, permanent recurrent laryngeal nerve paralysis, or post-
operative bleeding. The serum calcium in all patients was 
greater than 2.25 mmol/l during the preoperative period.  
　The serum corrected calcium (mmol/l) level was calcu-
lated by the following formula:Calcium concentration 
(mmol/l) + 1 - (albumin (g/l)/40) 
Statistical analysis
　The 109 patients were separated into two groups; patients 
with postoperative symptomatic hypocalcemia (with hy-
pocalcemia group) and patients without postoperative symp-
tomatic hypocalcemia (without hypocalcemia group). The 
data were expressed as the means ± standard deviation 
(SD) or medians. Continuous valuables were evaluated by 
Studentʼs t- test or Wilcoxonʼs test, as appropriate. Categori-
cal variables were analyzed using the chi-square test or 
Fisherʼs exact test. Fisherʼs exact test was applied if the theo-
retical frequency was less than five. A multiple logistic re-
gression analysis was used to assess simultaneous effects of 
factors on postoperative symptomatic hypocalcemia. The 
odds ratio and the 95% confidence interval were calculated 
for each covariate predictors included in the model. P value 
< 0.05 was considered to be statistically significant. These 
statistical analyses were performed using the SAS-JMP 
software programs for Windows (SAS Institute Inc. Cory, 
NC).
Results
　Table 1 shows the clinical characteristics of the 109 pa-
tients, which included 80 females and 29 males, with Gravesʼ 
disease. The median age of all patients was 34 years. The 
serum free T4 and T3 levels before the administration of KI 
were higher than the serum free T4 and T3 levels during the 
administration of KI (P < 0.001). Forty -four patients had 
high serum ALP concentrations during the preoperative pe-
riod before the administration of KI. The median length of 
the operation was 180 minutes, and the median blood loss 
was 90 g. 
　Table 2 shows the differences in the symptomatic and 
non-symptomatic groups. Twenty-four patients (22%) de-
veloped symptomatic hypocalcemia during the postopera-
tive period. There were no significant differences in the sex, 
age, length of operation, or blood loss between the two 
groups. The preoperative serum free T3 and free T4 levels 
before the KI administration were significantly higher in 
the with hypocalcemia group than the without hypocalce-
mia group (P < 0.001, both). The preoperative serum free T3 
and free T4 levels on admission were also significantly 
higher in the with hypocalcemia group (P = 0.03 and P < 
0.01, respectively). The preoperative serum calcium and 
corrected calcium levels were significantly also higher in 
the with hypocalcemia group (P = 0.05 and P = 0.03, respec-
tively), as was the preoperative serum ALP (P=0.01). 
　When a multiple logistic regression analysis was per-
formed to evaluate the confounding factors, the preopera-
tive serum free T4 levels before the KI administration was 
found to be significantly associated with postoperative 
symptomatic hypocalcemia (Table 3).
　Seventy-six patients had a high level of thyroid function 
(serum free T4 > 20.21 pmol/l) before the KI administra-
tion.  The sensitivity and specificity of high level of thyroid 
function before the KI administration was 0.92 and 0.37 for 
predicting postoperative symptomatic hypocalcemia Hy-
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perthyroidism provided reassuring information that patients 
with a normal thyroid function almost developed symptom-
atic hypocalcemia after surgery for Graveʼs disease (nega-
tive predictive values; NPV= 0.94). 
Discussion
　Calcium is present in serum in a form bound to albumin 
(40-45%), ionized (45-50%) or complexed to inorganic an-
ions (5-10%). The ionized calcium is physiologically the 
most important fraction (4). The symptoms of hypocalce-
mia generally correlate with the magnitude and speed of the 
decrease in the serum calcium level (5). Manifestations of 
neuromuscular irritability develop, and hypocalcemia can 
cause paresthesia of the distal extremities and circumoral 
area, the Chovostek and Trousseau sign, muscle cramps, 
laryngospasms, tetany, and seizures (5). In acute symptom-
atic hypocalcemia, these symptoms usually occur at con-
centrations of 1.88 mmol/l or less and warrant rapid paren-
teral administration of calcium (5). In this study, we targeted 
symptomatic hypocalcemia, because hypocalcemia needs 
to be treated as soon as possible when patients develop 
symptoms. Furthermore, the postoperative serum calcium 
levels in all patients decreased despite supplementation with 
calcium and the patients developing symptomatic hypocal-
cemia had significantly lower serum calcium levels than the 
non-symptomatic patients in a postoperative state (P < 0.001).
Table 1. Basic characteristics of 109 patients with Gravesʼ disease
　Factor Value normal range
Sex : female/male
Age (year)
Preoperative State (before KI administration)
calcium (mmol/l) 
corrected calcium (mmol/l) 
phosphorus  (mmol/l) 
albumin (g/dl) 
alkaline phosphatase (IU/l)
free T3 (pmol/l) 
free T4 (pmol/l)
TSH (mIU/l)
Preoperative State (during KI administration)
free T3 (pmol/l) 




Blood loss in operation (g)
valume of resection (g)
valume of the rest (g)
Postoperative State (post operative day 1)
calcium (mmol/l) 
































Values were given as mean ± standard devision for normal distribution or median (interquartile range) for skew distribution, except for sex. The 
serum corrected calcium (mmol/l) level was calculated by the following formula: Calcium concentration (mmol/l) + 1 - (albumin (g/l)/40). KI: po-
tassium Iodide, free T3: free triiodothyronine, free T4: free thyroxin, TSH: thyroid stimulating hormone
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Table 2. Comparison between patients with and without postoperative hypocalcemia
　Factor With hypocalcemia group
 (n=24)
Without hypocalcemia group 
(n=85)
P-value
Sex  female : male
Age (year)
Preoperative State (before KI administration)
calcium (mmol/l) 




free T3 (pmol/l) 
free T4 (pmol/l)
TSH (mIU/l)
Preoperative State (during KI administration)
free T3  (pmol/l) 
free T4  (pmol/l) 
TSH (mIU/l)
Operating state
Operation time (minutes) 
Blood loss in operation (g) 
valume of resection (g)
valume of the rest (g)
Postoperative State (post operative day 1)
calcium  (mmol/l) 


























































Values were given as mean ± standard devision for normal distribution or median (interquartile range) for skew distribution, except for sex. The serum cor-
rected calcium (mmol/l) level was calculated by the following formula: Calcium concentration (mmol/l) + 1 - (albumin (g/l)/40). KI: potassium iodide, free T3: 
free triiodothyronine, free T4: free thyroxin, TSH: thyroid stimulating hormone
Table 3. Odds ratio (OR) and 95% confidence interval (CI) for postoperative symptomatic hypocalcemia ,as assessed using 
multiple logistic regression analysis



















Free T4: free thyroxin, ALP: alkaline phosphatase
Free T4 and ALP were mesured before the administration of Potassium iodide.
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　According to a multivariate analysis, we showed the free 
T4 levels to be a risk factor for postoperative symptomatic 
hypocalcemia. This finding is supported by the fact that 
thyroid hormones have been associated with the bone me-
tabolism due to thyroid hormone receptors in human bone 
(6). Accelerated bone turnover caused by the direct stimula-
tion of bone cells triggers bone loss in patients with hyper-
thyroidism (6-8). In the hyperthyroid state, increased bone 
resorption leads to increased serum calcium concentrations 
and suppression of circulating parathyroid hormone (PTH) 
(9). According to Pantazi et al, after treatment for hyperthy-
roidism, the serum calcium concentrations tend to decline 
(9). At this time, increased PTH concentrations seem to play 
a role in calcium deposition to the bone (9). The abnormal 
calcium deposition to the bone is often observed as long as 
a year after the beginning of antithyroid treatment, despite 
the euthyroid conditions (9). Therefore, it is important to 
carefully evaluate to thyroid functions before preparation 
with KI when considering the status of preoperative bone 
metabolism, Postoperative normalization of bone metabo-
lism cause calcium deposition (10). These phenomena were 
kwon as hunger bone syndrome.
　Our current study showed that there is a relationship be-
tween hyperthyroidism and the incidence of postoperative 
symptomatic hypocalcemia. Preoperative hyperthyroidism 
were considered to be the risk of postoperative symptomatic 
hypocalcemia, although there were hardly postoperative 
symptomatic hypocalcemia in the patients with preopera-
tive euthyroidism.
　Some limitations associated with this study include its 
retrospective nature, and the fact that it was done in a single 
center. Accordingly, a prospective study in a larger number 
of patients will be required using well-matched groups of 
patients to confirm our findings. Moreover, for effective 
prevention of postoperative symptomatic hypocalcemia, it 
will be necessary to evaluate bone metabolism, such as by 
monitoring bone density and bone turnover markers, such 
as PTH and 25-hydroxy vitamin D3 (11). The serum calcium 
levels and intact PTH were also required when symptoms of 
hypocalcemia develop after the operation for correctly di-
agnosing the symptomatic hypocalcemia 
　In conclusion, the free T4 level before the administration 
of KI was found to be a risk factor for postoperative symp-
tomatic hypocalcemia. Patients who have hyperthyroidism 
and before the KI administration might therefore have in-
sufficient calcium in their bones and thereby may easily de-
velop postoperative symptomatic hypocalcemia. 
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